CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Filters
1 research outputs found
Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor
Author
AI McCormack
AP Heaney
+32 more
B Ambrosi
CE Fadul
D Lubke
E Horvath
E Rivera
EU Tan
F Amatori
FineRL FD
G Assie
G Kontogeorgos
G Widhalm
GA Kaltsas
J Hoek van der
Jeffrey N. Bruce
K Kovacs
K Kovacs
KR Mullan
LR Salgado
M Andreassen
Marie S. Thearle
MH Kulke
MH Kulke
ML Raffin-Sanson
Pamela U. Freda
PJ Jenkins
PJ Pernicone
Robert L. Fine
S Lim
S Mohammed
Steven R. Isaacson
VJ Moyes
Yoomi Lee
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
No full text
